Syngene International Ltd

NSE: SYNGENE · BSE: 539268 · Pharmaceuticals & Biotechnology · 38 announcements

Share price: ₹360.15
Market cap: ₹14,538 Cr
Revenue (annual): ₹3,739 Cr
Net profit (annual): ₹316.7 Cr
P/E (TTM): 65.8×Sector 47.4×
Promoter holding: 52.59%-0.09% QoQ
FII holding: 11.82%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 6 Earnings Call 5 Financial Results 4 Annual General Meeting 4 Other Announcement 3 Employee Stock Options 3 Board Meeting Outcome 3 Results Update 2 Merger & Restructuring 2 Legal & Regulatory 2 Dividend 1 Capital Structure Change 1 Board Meeting Date 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

7 Jul 2026 17:31 IST NSE

Legal & Regulatory

Syngene International Legal & Regulatory

Syngene disclosed a tax litigation update, receiving a Rs.0.86 Cr refund for AY 2014-15. The company expects no material financial impact, reducing contingent liability.

Value: ₹0.86 Cr

Read the filing ↗

19 May 2026 18:22 IST BSE

Legal & Regulatory

Syngene International Legal & Regulatory

Syngene International paid Rs. 0.04 Crore in penalties to BSE and NSE for board committee composition deviations. The company has since reconstituted the committee to ensure compliance.

Value: ₹0.04 Cr

Read the filing ↗